Wide scope prenatal diagnosis at Kuopio University Hospital 1997-1998: Integration of gene tests and fetal karyotyping

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 5, 2001, Pages 505-509

  Kallinen, Juuso ^a   Marin, Katja ^a   Heinonen, Seppo ^a   Mannermaa, Arto ^a   Palotie, Aarno ^b   Ryynänen, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPARTYLGLYCOSAMINURIA; CHROMOSOME MUTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FETUS; FETUS KARYOTYPING; FRAGILE X SYNDROME; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; NEURONAL CEROID LIPOFUSCINOSIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

COHORT STUDIES; FEMALE; FRAGILE X SYNDROME; GENETIC SCREENING; HETEROZYGOTE; HUMANS; KARYOTYPING; LYSOSOMAL STORAGE DISEASES; NEURONAL CEROID-LIPOFUSCINOSES; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES;

EID: 0034964308     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(00)00118-2     Document Type: Article

References (23)

1. Pedigree of mental defect showing sex-linkage
2. Late infantile progressive encephalopathy with disturbed poly-unsaturated fat metabolism
3. Large quantities of 2-acetamido-1-(beta-L-aspartamido)-1,2-dideoxyglucose in the urine of mentally retarded siblings
4. Molecular genetics of the Finnish disease heritage
5. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
6. Prevalence of carriers of premutation-size alleles of the FMR1 gene and implications for the population genetics of the fragile X syndrome
7. Early clinical symptoms and incidence of aspartylglucosaminuria in Finland
8. Applicability of a checklist for clinical screening of the fragile X syndrome
9. Aspartylglucosaminuria. Analysis of thirty-four patients
10. Aspartylglucosaminuria
11. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease
12. Spectrum of mutations in aspartylglucosaminuria
13. High prevalence of aspartylglycosaminuria among school-age children in eastern Finland
14. Enzyme replacement therapy in a mouse model of aspartylglycosaminuria
15. Infantile type of so-called neuronal ceroid-lipofuscinosis. Part I. A clinical study of 15 patients
16. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis
17. DNA diagnosis and identification of carriers of infantile and juvenile neuronal ceroid lipofuscinoses
18. Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures
19. Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: Application to aspartyl-glucosaminuria in Finland
20. Fragile-X: Neuropsychological test performance, CGG repeat lengths, and hippocampal volumes
21. Carrier diagnosis of the fragile X syndrome a challenge in antenatal clinics
22. Carrier screening for cystic fibrosis
23. DNA chips; state-of-the-art